“Securing & accelerating clinical development and market access for therapeutic innovations using Real-World disease and care modeling and simulation”
Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table organized by E4i. The theme of the round table was innovative therapies related to precision medicine. Alexandre Templier spoke about how real-world data (RWD) is set to revolutionize the clinical development and market […]
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland. Alexandre Templier (President and co-founder) and Frank Ahrens (Chief Commercial Officer) will be at BioTechX 22 in Basel, Switzerland on November 8th to 10th, 2022. You will be able to meet them there, and assist to Alexandre’s talk about “Combining RCT […]
Projeter l’efficacité d’un traitement en vie réelle (VR) à partir d’une étude clinique randomisée (ECR) : une approche utilisant le suréchantillonnage
Event: 11ème Colloque Données de Santé en vie réelle 2019, AFCROs, Paris, France Authors: C. Esnault, M. Génin, S. Ekhtiari, A. Civet View Poster Introduction Bien qu’il n’y ait pas encore de consensus formel sur l’emploi des modèles statistiques pour estimer l’efficacité d’un traitement en VR, le besoin de son évaluation plus systématique est largement reconnu [1] […]
